These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35738585)

  • 1. Tumor Budding as a Predictive Marker of Relapse and Survival in Patients With Stage II Colon Cancer.
    Saito K; Okuyama T; Miyazaki S; Oi H; Mitsui T; Noro T; Takeshita E; Ono Y; Urahashi T; Tajima H; Yoshitomi H
    In Vivo; 2022; 36(4):1820-1828. PubMed ID: 35738585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor budding and poorly-differentiated cluster in prognostication in Stage II colon cancer.
    Lee VWK; Chan KF
    Pathol Res Pract; 2018 Mar; 214(3):402-407. PubMed ID: 29487008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Budding as a Prognostic Marker in Primary Colon Cancer - A Single Center Experience.
    Dukoska DB; Zdravkovski P; Kostadinova-Kunovska S; Krsteska B; Karagjozov P; Dzambaz D; Nikolovski A; Antovic S; Jankulovski N; Petrushevska G
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2024 Jun; 45(2):47-58. PubMed ID: 39008643
    [No Abstract]   [Full Text] [Related]  

  • 4. Is there no need to discuss adjuvant chemotherapy in stage II colon cancer patients with high tumor budding and lymphovascular invasion?
    Zenger S; Gurbuz B; Can U; Erginoz E; Ozata IH; Yilmaz SP; Taskin OC; Peker O; Adsay V; Balik E; Bugra D
    Langenbecks Arch Surg; 2023 Mar; 408(1):127. PubMed ID: 36973561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of tumor budding on the benefit of adjuvant chemotherapy in stage II colorectal cancer: a retrospective observational study.
    Ran X; Chen Y; Liu C; Xiao H; Su X; Chen Z; Du J; He J; Zhong P; Li M; Dai N; Chen C
    J Gastrointest Oncol; 2024 Aug; 15(4):1545-1555. PubMed ID: 39279933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial.
    Ueno H; Ishiguro M; Nakatani E; Ishikawa T; Uetake H; Matsuda C; Nakamoto Y; Kotake M; Kurachi K; Egawa T; Yasumasa K; Murata K; Ikawa O; Shinji S; Murotani K; Matsui S; Teramukai S; Tomita N; Sugihara K;
    J Clin Oncol; 2019 Aug; 37(22):1886-1894. PubMed ID: 31180819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myxoid stroma is associated with postoperative relapse in patients with stage II colon cancer.
    Okuyama T; Sameshima S; Takeshita E; Mitsui T; Noro T; Ono Y; Noie T; Ban S; Oya M
    BMC Cancer; 2020 Sep; 20(1):842. PubMed ID: 32883261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of tumor budding in a thoroughly characterized stage II colon cancer population in the context of a national screening program.
    Pihlmann Kristensen M; Korsgaard U; Timm S; Hansen TF; Zlobec I; Hager H; Kjær-Frifeldt S
    Hum Pathol; 2024 Apr; 146():15-22. PubMed ID: 38428823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.
    Eriksen AC; Sørensen FB; Lindebjerg J; Hager H; dePont Christensen R; Kjær-Frifeldt S; Hansen TF
    Int J Colorectal Dis; 2018 Aug; 33(8):1115-1124. PubMed ID: 29785462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor budding as an index to identify high-risk patients with stage II colon cancer.
    Nakamura T; Mitomi H; Kanazawa H; Ohkura Y; Watanabe M
    Dis Colon Rectum; 2008 May; 51(5):568-72. PubMed ID: 18286339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour budding is a reproducible index for risk stratification of patients with stage II colon cancer.
    Lai YH; Wu LC; Li PS; Wu WH; Yang SB; Xia P; He XX; Xiao LB
    Colorectal Dis; 2014 Apr; 16(4):259-64. PubMed ID: 24118729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and predictive values of tumour budding in stage IV colorectal cancer.
    Nagata K; Shinto E; Yamadera M; Shiraishi T; Kajiwara Y; Okamoto K; Mochizuki S; Hase K; Kishi Y; Ueno H
    BJS Open; 2020 Aug; 4(4):693-703. PubMed ID: 32472647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological risk factors of Stage II colon cancer: results of a prospective study.
    Santos C; López-Doriga A; Navarro M; Mateo J; Biondo S; Martínez Villacampa M; Soler G; Sanjuan X; Paules MJ; Laquente B; Guinó E; Kreisler E; Frago R; Germà JR; Moreno V; Salazar R
    Colorectal Dis; 2013 Apr; 15(4):414-22. PubMed ID: 22974322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
    Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
    Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Obesity and Histological Tumor Budding in Patients With Nonmetastatic Colon Cancer.
    Gan T; Schaberg KB; He D; Mansour A; Kapoor H; Wang C; Evers BM; Bocklage TJ
    JAMA Netw Open; 2021 Apr; 4(4):e213897. PubMed ID: 33792733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR).
    Basile D; Broudin C; Emile JF; Falcoz A; Pagès F; Mineur L; Bennouna J; Louvet C; Artru P; Fratte S; Ghiringhelli F; André T; Derangère V; Vernerey D; Taieb J; Svrcek M;
    Ann Oncol; 2022 Jun; 33(6):628-637. PubMed ID: 35306156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer.
    Park JS; Chon HJ; Jeung HC; Shin SJ; Rha SY; Ahn JB; Lee KY; Kim NK; Chung HC
    J Cancer Res Clin Oncol; 2016 Sep; 142(9):2051-9. PubMed ID: 27447697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of tumor budding detection in stage II colon cancer].
    Liu SJ; Yang XH; Ren JQ; Zhu XJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Aug; 16(8):730-4. PubMed ID: 23980042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of apical lymph node metastasis in right colon cancer.
    Wang LM; Hirano YM; Ishii TM; Kondo HK; Hara KK; Obara N; Asari MH; Yamaguchi SK
    Int J Colorectal Dis; 2020 Oct; 35(10):1887-1894. PubMed ID: 32514722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Number of negative lymph nodes with a positive impact on survival of stage III colon cancer; a retrospective observation study for right side and left side colon.
    Kuo YH; You JF; Hung HY; Chin CC; Chiang JM; Chang CH
    BMC Cancer; 2022 Jan; 22(1):126. PubMed ID: 35100975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.